Home › Blood Cancers › NCT07714044
Rutgers University Study of the Genetics of Blood Cancers
The Rutgers University Study of the Genetics of Blood Cancers
Who can join
Ages 18 to 110 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * age 18 years or older * currently living in the United States * have access to the internet and a computer, laptop, tablet or smartphone * willing to provide written informed consent for participation * willing to provide DNA via a saliva sample using a collection kit mailed to your home * willing to complete a survey with questions about health related to the study of blood cancer. Exclusion Criteria: * Not able to meet or fulfill any of the inclusion criteria
About the study
The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.
Sponsor: Rutgers, The State University of New Jersey · Participants: 10,000 · Started: Sep 22, 2026
Contact the study team
- Tara Matise, PhD · Phone: 848-445-3125
Official record on ClinicalTrials.gov — NCT07714044
Locations in the U.S.
| New Jersey | Rutgers University, Piscataway |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.